|
|
Fleshy Lesions on a 32-Year-Old Woman
|
| Link ID |
3222 |
| Title |
Fleshy Lesions on a 32-Year-Old Woman |
| Url |
http://www.medscape.com/viewprogram/8751?src=rss |
| Description |
A 32-year-old woman presents to the emergency department (ED) with several flesh-colored papules and patches with well-defined borders on her face, trunk, and upper extremities. She first developed the lesions at 10 years of age. The patient’s medical and surgical history includes environmental allergies, frequent episodes of bronchitis, and excision of recurring skin papules. What is the diagnosis? eMedicine Case Presentations |
| Category |
Articles > Dermatology |
| Keywords |
|
| Date |
Feb 14, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Dermatology |
| 2. |
FDA Approvals: PrandiMet, Doryx, Doxil
|
|
|
The FDA has approved repaglinide plus metformin HCl tablets (PrandiMet), doxycycline hyclate 150-mg tablets (Doryx), and a new indication for doxorubicin liposome injection (Doxil). Medscape Medical News
|
| 5. |
Targeting N-Cadherin Boosts Melanoma Response to Chemotherapy
|
|
|
A novel pentapeptide -- ADH-1 -- that disrupts N-cadherin-mediated cell adhesion, enhances the response of melanoma to cytotoxic chemotherapy, according to the results of an animal study published in the May 15th issue of Cancer Research. Reuters Health Information
|
|
|
